Approval · Notice of Compliance 18188 · 2016
MOSASPRAY: Notice of Compliance 18188
Issued June 17, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18188
- Date
- June 17, 2016
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Canadian reference product
- NASONEX
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MOSASPRAY | 02455870 | Cancelled Post Market |
Medicinal ingredients
- MOMETASONE FUROATE MONOHYDRATE 50 MCG per SPR